Multidata Systems International Company Overview and FDA Warning

Author

Reads 13K

Networking cables plugged into a patch panel, showcasing data center connectivity.
Credit: pexels.com, Networking cables plugged into a patch panel, showcasing data center connectivity.

Multidata Systems International is a medical device company that has been in operation for several decades.

Their products are used in various medical settings, including hospitals and clinics.

The company has faced regulatory issues with the FDA, which has issued a warning letter due to concerns over their manufacturing practices.

The FDA warning highlights specific issues with the company's quality control procedures and their failure to address these concerns.

A different take: St. Louis Post-Dispatch

FDA Actions

The FDA has taken action against Multidata Systems International, releasing a warning about issues with their medical devices. The agency is concerned about the potential risk to patients from these devices.

The FDA knows of at least 2 Multidata medical devices that were manufactured and distributed in the US without proper clearance or review. This is a serious issue, as it puts patients at risk.

Multidata has been under a Consent Decree of Permanent Injunction with the US District Court for the Eastern District of Missouri since 2003. This decree prohibits the company from designing, manufacturing, processing or distributing medical devices.

Credit: youtube.com, Upgrading the FDA Adverse Event Reporting Systems - FAERS

The FDA has discovered that Multidata manufactured and distributed medical devices in violation of this decree, including repairing and exchanging Waterphantom devices for newer design models. This is a clear disregard for the rules.

Healthcare providers may be unaware of the risks associated with Multidata's devices, so the FDA is urging facilities to discontinue use of any devices manufactured by Multidata. This is a precautionary measure to protect patients.

The FDA has sent a letter demanding a halt to any designing, manufacturing, processing, packing, repacking, labeling, installing, holding for sale or distribution of any medical devices from Multidata. This is a serious warning, and Multidata must take action.

FDA Warning

The FDA has issued a warning about Multidata Systems International's medical devices. The agency has found that the company has been manufacturing and distributing devices without proper clearance or review.

At least two Multidata medical devices have been identified as problematic: the Real Time Dosimetry Waterphantom System and the Dual Channel Electrometer. These devices are accessories to radiation therapy devices.

If this caught your attention, see: RF Micro Devices

Credit: youtube.com, What Happens After FDA Warning Letter? - CountyOffice.org

Multidata has been under a Consent Decree of Permanent Injunction with the U.S. District Court for the Eastern District of Missouri since 2003. The decree prohibits the company from designing, manufacturing, processing or distributing medical devices.

The FDA is concerned about the potential risk to patients from the devices. The agency has not reviewed any 510(k) materials from the company.

Health care providers may be unaware of the risks associated with the devices. The FDA is urging facilities to discontinue use of any devices manufactured by Multidata.

Customers with Multidata devices should discontinue use and only utilize FDA-cleared devices.

See what others are reading: 11th District Cost of Funds Index

Company Information

Multidata Systems International is a leading provider of data acquisition and control systems. They have been in the industry for over 30 years.

Their headquarters is located in the United States, with a global presence through their network of distributors and partners.

Harold Raynor

Writer

Harold Raynor is a seasoned writer with a keen eye for detail and a passion for sharing knowledge with others. With a background in business and finance, he brings a unique perspective to his writing, tackling complex topics with clarity and ease. Harold's writing portfolio spans a range of article categories, including angel investing, angel investors, and the Los Angeles venture capital scene.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.